Community advisory boards: Experiences and common practices of clinical and translational science award programs.
Community advisory board
best practices
community engagement
community partnerships
implementation
survey
Journal
Journal of clinical and translational science
ISSN: 2059-8661
Titre abrégé: J Clin Transl Sci
Pays: England
ID NLM: 101689953
Informations de publication
Date de publication:
Oct 2019
Oct 2019
Historique:
received:
04
04
2019
revised:
23
05
2019
accepted:
30
05
2019
entrez:
30
10
2019
pubmed:
30
10
2019
medline:
30
10
2019
Statut:
epublish
Résumé
Community advisory boards (CABs) are a valuable strategy for engaging and partnering with communities in research. Eighty-nine percent of Clinical and Translational Science Awardees (CTSA) responding to a 2011 survey reported having a CAB. CTSAs' experiences with CABs are valuable for informing future practice. This study was conducted to describe common CAB implementation practices among CTSAs; document perceived benefits, challenges, and contributions; and examine their progress toward desirable outcomes. A cross-CTSA collaborative team collected survey data from respondents representing academic and/or community members affiliated with CTSAs with CABs. Data representing 44 CTSAs with CABs were analyzed using descriptive statistics. A majority of respondents reported practices reflecting respect for CAB members' expertise and input such as compensation (75%), advisory purview beyond their CTSA's Community Engagement program (88%), and influence over CAB operations. Three-quarters provide members with orientation and training on roles and responsibilities and 89% reported evaluating their CAB. Almost all respondents indicated their CTSA incorporates the feedback of their CABs to some degree; over half do so a lot or completely. This study profiles practices that inform CTSAs implementing a CAB and provide an evaluative benchmark for those with existing CABs.
Identifiants
pubmed: 31660246
doi: 10.1017/cts.2019.389
pii: 00389
pmc: PMC6813515
doi:
Types de publication
Journal Article
Langues
eng
Pagination
218-226Subventions
Organisme : NIMHD NIH HHS
ID : U54 MD002329
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002240
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002345
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR003107
Pays : United States
Informations de copyright
© The Association for Clinical and Translational Science 2019.
Références
Prog Community Health Partnersh. 2018;12(2):145-156
pubmed: 30270224
J Acquir Immune Defic Syndr. 2012 Apr 1;59(4):e78-81
pubmed: 22407304
BMC Med Res Methodol. 2016 Jul 11;16:80
pubmed: 27401678
Clin Transl Sci. 2013 Aug;6(4):292-6
pubmed: 23919364
Prev Chronic Dis. 2011 May;8(3):A70
pubmed: 21477510
J Acquir Immune Defic Syndr. 2003 Aug 1;33(4):513-20
pubmed: 12869841
J Clin Transl Sci. 2018 Aug 08;2(2):66-72
pubmed: 31660220
J Clin Transl Sci. 2018 Feb;2(1):8-13
pubmed: 31497317
J Health Care Poor Underserved. 2018;29(4):1529-1543
pubmed: 30449761
Prog Community Health Partnersh. 2017;11(4):367-377
pubmed: 29332850